Related by context. All words. (Click for frequent words.) 79 CYT# potent vascular disrupting 79 essential thrombocythemia 78 kidney urologic 76 K ras mutations 76 Epidermal Growth Factor Receptor 76 myeloproliferative disorders 75 hypereosinophilic syndrome 75 Ribavirin causes 75 familial amyloidotic polyneuropathy FAP 75 Sezary syndrome 75 Systemic lupus erythematosus SLE 75 Factor Receptor 75 Systemic lupus erythematosus 74 myeloproliferative neoplasms 74 Myelofibrosis 74 epithelial tumors 74 complement inhibitor eculizumab 74 targeted radiotherapeutic 74 erlotinib Tarceva ® 74 Leukemias 74 Chemokine Receptor 74 oral prodrug 73 MKC# MT 73 dasatinib Sprycel ® 73 JAK2 enzyme 73 candidates Azedra TM 73 FLT3 73 systemic autoimmune 73 IAP inhibitor 73 V#F mutation 73 novel VDA molecule 73 chronic eosinophilic leukemia 73 T#I [002] 73 CYP#A# CYP#D# 73 underlying vasculopathy 73 pan HDAC inhibitor 73 myeloproliferative diseases 73 receptor tyrosine kinase inhibitor 73 Gleevec resistant 73 Protein Kinase C 73 mycosis fungoides 73 Xanafide 72 Carcinoid tumors 72 protein tyrosine phosphatase 1B 72 metastatic colorectal 72 polycythemia vera PV 72 Fludara ® 72 benign prostatic hypertrophy BPH 72 Enzastaurin 72 vapreotide acetate 72 histone deacetylase HDAC 72 orally administered inhibitor 72 thalidomide Thalomid 72 metastatic neuroendocrine tumors 72 non alcoholic steatohepatitis 72 MAGE A3 ASCI 72 Immunotherapeutic 72 R Saizen R 72 myelodysplastic myeloproliferative diseases 72 developing Bicifadine serotonin 72 GRNOPC1 contains 72 orally bioavailable mimics 72 TTR amyloidosis 72 HER2 overexpression 72 MKC# MKC# PP 72 LHRH antagonists 72 Kuvan sapropterin dihydrochloride 72 Squamous 72 Epstein Barr Virus EBV 72 hypoxia inducible factor 71 MGd 71 protein tyrosine phosphatases 71 NS5B polymerase 71 HER1 71 small molecule thrombopoietin 71 androgen receptor AR 71 Aurora kinase 71 Sudhir Agrawal D.Phil 71 ALN HPN 71 Epratuzumab 71 Acute myeloid leukemia AML 71 sPLA2 71 essential thrombocythemia ET 71 anaphylactic reactions bronchospasm 71 oral Janus kinase 71 vinca alkaloid 71 Mg Usa 71 systemic fungal infections 71 Sapacitabine 71 PNP inhibitor 71 Lymphocytic 71 recurrent metastatic ovarian cancer 71 haematologic 71 selective inhibition 71 Liprotamase 71 EGFR HER2 71 interleukin IL -# 71 imatinib resistant 71 torsade de pointes 71 herpes zoster shingles 71 hyperplasia BPH 71 cytopenias 71 sunitinib Sutent ® 71 Monoclonal 71 c MET 71 Novel Oral 71 Prostacyclin 71 Voreloxin 71 MCSP respectively 71 included exfoliative dermatitis 71 microtubule inhibitor 71 systemic anaplastic large 71 Vidaza ® 71 lexidronam injection 71 HGS ETR1 mapatumumab 71 certain protein tyrosine 71 vWD 71 Clusterin 71 AAG geldanamycin analog 71 neutropenia dehydration dyspnea 71 RNAi therapeutic targeting 71 diarrhea predominant irritable 70 5 HT6 receptor 70 Kit CD# positive 70 docetaxel Taxotere ® 70 chronic myeloid 70 neuropathic pain metabolic diseases 70 psoriasis rheumatoid arthritis 70 investigational monoclonal antibody 70 NAGS deficiency 70 Alfacell proprietary ribonuclease 70 neuro inflammatory 70 cell adhesion molecule 70 tumor xenograft models 70 Prodarsan R 70 LymphoStat B belimumab 70 Chronic lymphocytic leukemia 70 pancreatic prostate 70 Personalized Immunotherapy 70 benign neoplasms 70 Solazed TM 70 histone deacetylase HDAC inhibitors 70 recurrent glioblastoma multiforme 70 delta gamma agonist 70 DNA methyltransferase inhibitors 70 Eculizumab 70 intravesical infusion therapy 70 toenail onychomycosis 70 Hsp# Inhibitor 70 ENMD # 70 Fas ligand 70 colorectal carcinoma 70 sorafenib tablets 70 small molecule activators 70 including eniluracil ADH 70 Hurthle cell 70 Glucocorticoids 70 ADAMTS# 70 papillary renal cell carcinoma 70 Romiplostim 70 Advanced Renal Cell 70 INCB# [003] 70 YONDELIS 70 Warfarin Coumadin 70 Janus kinase 70 Hepatocellular Carcinoma HCC 70 Methylnaltrexone 70 fibrotic disease 70 samarium Sm 70 neuroendocrine cancers 70 EGFr 70 induce orthostatic hypotension 70 sarcoma melanoma 70 Cathepsin B 70 QUADRAMET R 70 VEGF inhibitors 70 Cardiotoxicity 70 acetonide FA 70 biologic therapeutics 70 bevacizumab Avastin ® 70 BCG refractory carcinoma 70 M2 subunit 70 pheochromocytoma 70 IMiDs R 70 alpha folate receptor 70 Serostim R 70 alvespimycin 70 basal cell carcinoma BCC 70 EGFR tyrosine kinase inhibitors 70 peptidic compound 70 gastric carcinoma 70 Talabostat 70 bevacizumab Avastin R 70 infectious diseases autoimmune diseases 70 liver colon rectal 70 metaglidasen 70 AEG# 69 IL# PE#QQR 69 immunological diseases 69 ADP receptor antagonist 69 PI3K Akt 69 MAbs targeting 69 neutropenia thrombocytopenia 69 TLR9 agonists 69 XL# anticancer compounds 69 5 HT2A inverse 69 chimeric monoclonal antibody 69 products MKC# PP 69 Romidepsin 69 demyelinating disease 69 tiapamil 69 pralatrexate injection folate analogue 69 LHRH receptor positive 69 anionic backbone 69 BRAF kinase 69 vaginal candidiasis 69 vWF 69 Zemiva TM 69 cardio metabolic diseases 69 Provectus Pharmaceuticals specializes 69 NPM1 mutation 69 Anthracycline 69 gefitinib Iressa 69 Papillary 69 Ovitrelle R Serostim 69 Tay Sachs thalassemia 69 Adenoviral 69 anemias 69 alpha interferons 69 atypical hemolytic uremic syndrome 69 selective modulator 69 Tumor Necrosis Factor 69 γ secretase 69 vascular occlusive diseases 69 Trastuzumab DM1 69 pathophysiological effects 69 ALN TTR 69 Safinamide 69 TNF Tumor Necrosis Factor 69 peptibody 69 treat benign prostatic 69 luteinizing hormone releasing 69 erythematosus 69 PI3K AKT 69 imatinib Gleevec ® 69 TRAIL induced apoptosis 69 TTR gene 69 Kinase Inhibitor 69 Aurora Kinase 69 superficial basal cell carcinoma 69 multiple sclerosis psoriasis 69 nilotinib Tasigna ® 69 tigecycline 69 GNAQ 69 Seliciclib 69 biologic pathway 69 non nucleoside HCV 69 ANCA associated 69 constipation OIC 69 Temsirolimus 69 serine threonine 69 RAF kinase VEGFR 69 compound ITMN 69 ERK1 2 69 engineered RAP peptides 69 secretory phospholipase A2 69 acetylcholinesterase AChE 69 Tezampanel 69 Acute myeloid leukemia 69 mTOR mammalian target 69 HCV NS5B polymerase 69 Factor VEGF 69 hematologic disorders 69 itraconazole Sporanox 69 myeloid 69 allogeneic epidermal 69 aplastic anemia AA 69 cMET 69 proteasome inhibitor 69 post herpetic 69 unresectable tumors 69 polyneuropathy HIV DSP 69 Interferon gamma 69 sodium thiosulfate STS 69 Janus Kinase 69 nucleoside analog 69 Mg Uk 69 MALT lymphoma 69 Vorinostat 69 cutaneous T 69 erythematosus SLE 69 A3 adenosine receptor 69 Viprovex R 69 INSPIRE Trial Phase III 69 riociguat 69 cetuximab Erbitux R 69 histone deacetylase HDAC inhibitor 69 candidemia 69 gastrointestinal mucositis 69 Vidaza azacitidine 69 JAK1 69 FGFR1 69 Azacitidine 69 myocardial infarction ventricular fibrillation 69 VEGFR2 inhibitor 69 angiogenic responses 69 HDAC Inhibitor 69 herpetic keratitis 69 Recombinant Human 69 antisense inhibitors 69 PDGF receptor 69 Dapagliflozin 69 Gamunex C 69 pulmonary hypertension PH 69 selective kinase inhibitor 69 pyrimidines 69 siRNA binds 69 cyclin dependent kinase inhibitor 69 phosphatidylinositol 3 69 histone deacetylase 69 Signaling Pathway 69 Enkephalin 69 gene rearrangements 69 Squalamine 69 Cutaneous T 69 Complicated Skin 69 Anti Tumor 69 refractory chronic lymphocytic 69 Atopic dermatitis 69 HER pathway 69 lung cancer NSCLC 69 gastric adenocarcinoma 69 Aviptadil 69 chronic thromboembolic pulmonary 69 Teriflunomide 69 Vidofludimus 69 HDAC inhibition 68 proto oncogene 68 gastro intestinal inflammation 68 Aflibercept 68 cisplatin resistant 68 investigational humanized monoclonal antibody 68 topoisomerase II inhibitor 68 Tumor Response 68 p# mitogen activated 68 rxRNA 68 hepatoma 68 histone deacetylase inhibitor 68 Metastatic breast cancer 68 factor receptor FGFR 68 pharmacodynamic biomarkers 68 Estrogen Receptor 68 Pseudomonas aeruginosa infections 68 thymidylate synthase TS 68 ovarian breast 68 drugable targets 68 Gel repository corticotropin injection 68 hypertrichosis occurred 68 cytomegalovirus CMV 68 haematological malignancies 68 myeloproliferative 68 mda 7 68 triciribine phosphate monohydrate 68 Epstein Barr virus EBV 68 Venous thromboembolism 68 vesicular monoamine transporter 68 cause cardiac channelopathies 68 either acutely decompensated 68 serine protease 68 LRP5 68 virus AAV 68 Hedgehog Pathway Inhibitor 68 CDK cyclin dependent 68 tubulin inhibitor 68 CRTH2 68 D aspartate NMDA receptor 68 Philadelphia Chromosome Positive 68 product platforms AZX# 68 Tyrosine Kinase Inhibitor 68 novel peptide 68 Inflammatory Diseases 68 alkylating 68 Alzheimer disease cognitive impairment 68 neuropathic pain spasticity 68 Haptoglobin 68 Dasatinib 68 bone marrow suppression 68 J Am Coll 68 calcineurin inhibitors 68 hepatocellular carcinomas 68 carcinoid 68 trastuzumab DM1 T DM1 68 MTP inhibitor 68 naturally occurring neuroprotective 68 Zollinger Ellison Syndrome 68 reversible inhibitors 68 coronary stent merged 68 MYCAMINE 68 TRANSDUR ® 68 Toxicities 68 imatinib Gleevec 68 Tekmira LNP technology 68 dopamine D2 68 T#I mutant 68 Antitumor Activity 68 myeloproliferative neoplasms MPNs 68 FOLOTYN ® 68 Respiratory syncytial virus RSV 68 mucinous 68 iobenguane 68 Sym# 68 treat chronic sinusitis 68 Platelet Derived Growth 68 CD# monoclonal antibody 68 kinase inhibition 68 Onalta TM 68 NS5b 68 abnormal p# 68 choroidal neovascularization 68 echinocandin 68 metastatic malignant 68 mTOR inhibitors 68 oral picoplatin 68 Carcinomas 68 fusion enhancers 68 chemokine receptor 68 Hashimoto thyroiditis 68 Cytomegalovirus CMV 68 leukotriene pathway 68 Acute Bacterial Sinusitis ABS 68 Tasimelteon 68 efalizumab 68 Upregulation 68 Disease IBD 68 Peginterferon alfa 2b 68 Silodosin 68 skeletal metastases 68 stable nucleic acid 68 myopathy rhabdomyolysis 68 SUTENT ® 68 IMA# 68 immune modulatory 68 Tasigna prolongs 68 neovascular diseases 68 Endologix Powerlink System 68 dasatinib Sprycel 68 IgG1 monoclonal antibody 68 Randomized Double blind 68 CCX# 68 brand ciclesonide HFA 68 Deforolimus 68 idiopathic myelofibrosis 68 carcinoma HCC 68 lung pancreatic 68 paraganglioma 68 KL4 Surfactant 68 Orally administered 68 FGFR3 68 Golimumab 68 5 HT2A serotonin 68 Bucindolol 68 Rigel R# 68 Meets Primary Endpoint 68 gastrointestinal stromal tumor 68 myelodysplastic syndrome MDS 68 anthracycline induced 68 idiopathic thrombocytopenic purpura ITP 68 Pneumocystis pneumonia PCP 68 Antithrombin 68 Anidulafungin 68 pyrexia mucositis sepsis febrile 68 eIF 4E 68 ocular formulation 68 Naive Patients 68 Dalbavancin 68 leukemia AML 68 prostanoid 68 intra abdominal infections 68 telomerase reverse transcriptase 68 pharmacokinetic interactions 68 Darinaparsin 68 accumulate preferentially 68 PR interval prolongation 68 CYP#A# substrate 68 multitargeted 68 opioid receptor antagonist 68 Evoltra ® 68 cell lymphoma CTCL 68 apoptotic pathway 68 serine threonine kinase 68 RhuDex TM 68 erythema nodosum 68 erlotinib Tarceva 68 ADPKD 68 rHuPH# recombinant human 68 immuno modulatory 68 pituitary adenomas 68 PSMA ADC 68 nephrogenic fibrosing dermopathy 68 soluble tumor necrosis 68 Dementia Related Psychosis 68 2 inhibitor CYT# 68 Oncogenic 68 CDK inhibitor 68 heparin induced thrombocytopenia 68 Factor VIIa 68 liposomal formulation 68 Zolinza 68 busulfan 68 Friedreich Ataxia FRDA 68 adrenocortical cancer 68 serotonergic drugs 68 Soft Tissue Sarcoma 68 huC# DM4 68 demonstrated antitumor activity 68 Zorbtive TM 68 2 methoxyestradiol 68 protein kinase C 68 Hematopoietic 68 signal transduction inhibitors 68 IMiDs ® 68 HBeAg negative 68 exocrine 68 humanized monoclonal antibodies 68 receptor subtype 68 TACI Ig 68 oral nucleoside analogue 68 C5aR 68 Cyclin E 68 hypervascular tumors 68 Azedra 68 invasive candidiasis 68 MEK inhibitors 68 breast carcinomas 68 sorafenib Nexavar 68 including thyroiditis RA 68 PKC# 68 antiangiogenesis therapies 68 TKB# 68 PAOD 68 immunologic diseases 68 Leukine ® 68 small molecule activator 68 NF kB pathway 68 renal cell carcinomas 68 R lenalidomide 68 inactivating mutations 68 Vidaza R 68 Refractory Hodgkin Lymphoma 68 posterior uveitis 68 IRX 2 68 Trastuzumab 67 1 diabetes T1D 67 gastrointestinal stromal 67 haematopoietic 67 hamartomas 67 Tolvaptan 67 ALN PCS 67 molecular biomarkers 67 JAK inhibitors 67 HCV protease inhibitor 67 pentamidine 67 leiomyomas 67 polyglutamate 67 Aplidin R 67 superficial basal cell carcinomas 67 Decitabine 67 Hepatocytes 67 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 67 galiximab 67 pancreatic colon 67 somatostatin analogue 67 colorectal bladder 67 tyrosine kinase receptor 67 Hereditary angioedema HAE 67 relapsed leukemia 67 TELINTRA 67 Diffuse Large B 67 leukocyte adhesion 67 Degarelix 67 Homspera TM 67 transthyretin TTR 67 5alpha reductase 67 primary hyperparathyroidism 67 Arsenic trioxide 67 ceroid lipofuscinosis NCL 67 methylnaltrexone bromide 67 Oral NKTR 67 gastrointestinal stromal tumors GISTs 67 polycythemia vera essential thrombocythemia 67 Streptococcus pyogenes 67 methicillin susceptible Staphylococcus aureus 67 nucleoside analogues 67 gemcitabine Gemzar 67 NSCLC tumors 67 Glufosfamide 67 triggers apoptosis programmed 67 tyrosine kinase inhibitors TKIs 67 ovarian pancreatic 67 JNK pathway 67 Chronic HCV 67 INS# [001] 67 Phase 2a Clinical Trial 67 generation purine nucleoside 67 Liposomal 67 Cetrorelix 67 Chronic Lymphocytic Leukemia CLL 67 trastuzumab Herceptin ® 67 interferon IFN 67 OMP #R# 67 mGluR5 negative 67 Umbilical cord stem cells 67 paragangliomas 67 lenalidomide Revlimid R 67 Escherichia coli Klebsiella pneumoniae 67 imatinib resistance 67 prokinetic agent 67 CEQ# 67 transthyretin amyloidosis 67 evaluating tivozanib 67 PROSTASCINT R 67 chemically modified tetracyclines 67 Exelixis compounds 67 diagnostic biomarker 67 camptothecin CPT 67 severe hypersensitivity reactions 67 HuLuc# 67 MAPK pathway 67 NKG2D 67 Akt activation 67 ara C 67 anti angiogenic agents 67 sodium glucose cotransporter 67 gastrointestinal disorders ATI 67 nutlin 3a 67 Locked Nucleic Acid LNA 67 serologically active systemic lupus 67 rheumatoid arthritis systemic lupus 67 bazedoxifene conjugated estrogens 67 Mitoxantrone 67 oncolytic virus therapies 67 hip osteonecrosis avascular 67 unique alkylating agent 67 TO AVOID PREGNANCY WHILE 67 immune modulating 67 tumor lysis syndrome 67 platform HDL Mimetic 67 Pertuzumab 67 cortisol synthesis 67 diagnostic molecular imaging 67 IL #p# 67 cIAI 67 lichen planus 67 basal cell carcinoma squamous 67 NB S# strontium malonate 67 keloid scarring 67 antimetabolite 67 Antifungals 67 Progressive Multifocal Leukoencephalopathy 67 Darapladib 67 NASH Huntington 67 indinavir Crixivan 67 QTc prolongation 67 Myelodysplastic syndromes MDS 67 glial tumors 67 endogenous ligands 67 macrolide antibiotic 67 IMPACS TM compounds 67 MyVax R 67 multi kinase inhibitor 67 ErbB1 67 mediated autoimmune diseases 67 Wafer polifeprosan 67 homozygous familial hypercholesterolemia 67 secondary hyperparathyroidism 67 FGFR2 67 Viprovex TM 67 Peptide YY 67 Cytotoxic 67 granzyme 67 histologies 67 Serostim ® 67 transplantation HCT 67 vinorelbine tartrate 67 ATC ovarian cancer 67 NS#/#A protease 67 Hypotension 67 Sjögren syndrome 67 potent topoisomerase II 67 poly ADP ribose polymerase 67 pulmonary metastases 67 prostate carcinoma 67 trial evaluating PRX# 67 enzyme cofactor 67 activin 67 osteosarcoma Ewing sarcoma 67 CD4 monoclonal antibody 67 Cytarabine 67 oncologic diseases 67 Bosutinib 67 cholesteryl ester transfer 67 CEA CD# Her2 67 FGFR 67 GW# [003] 67 proteasome inhibitors 67 ophthalmology oncology 67 oral proteasome inhibitor 67 Interferons 67 endothelin receptor antagonists 67 Helicobacter pylori H. pylori 67 BCR ABL inhibitors 67 cystic fibrosis chronic pancreatitis 67 granulomatous 67 Amgen Neulasta R 67 PDGFR 67 cisplatin gemcitabine 67 dyslipidemia hypertension diabetes 67 selectively inhibited 67 lintuzumab SGN 67 Anti VEGF 67 Angiotensin II 67 cell adhesion molecules 67 murine model 67 systemic juvenile idiopathic 67 lung carcinomas 67 dyskinesia PD LID 67 mitogen activated protein kinase 67 posaconazole 67 trastuzumab Herceptin R 67 replicon 67 delipidation 67 molecularly targeted 67 interferon alpha IFN 67 catheter occlusion 67 Antigenics QS 67 Nilotinib 67 candidiasis 67 activating mutation 67 Acute Myeloid Leukemia AML 67 endoplasmic reticulum stress 67 oral JAK#/JAK# inhibitor 67 sulfonylhydrazine class 67 hormone LHRH antagonist 67 receptors PPARs 67 neuroblastoma tumors 67 dextromethorphan quinidine 67 refractory gout 67 immune modulator 67 selective antagonist 67 potent anti angiogenic 67 CysDisplay R 67 mertansine 67 SinuNase TM 67 Flt3 67 endosomal release 67 Esophagitis 67 Initiates Enrollment 67 diarrhea fatigue asthenia 67 proliferator activated receptor 67 Panzem R 67 Pemetrexed 67 erosive gastritis 67 novel emulsion formulation 67 receptor modulators 67 denileukin diftitox 67 anti CD3 antibody 67 Bevacizumab 67 gastrointestinal stromal tumors 67 RAS MAPK pathway 67 vitreoretinal disorders 67 transthyretin TTR mediated amyloidosis 67 unknown etiology 67 biodefense pathogens 67 photodynamic therapy PDT 67 selective antagonists 67 Letairis ambrisentan 67 FUSILEV enhances 67 benzimidazole 67 antibody MT# 67 nonsmall cell lung cancer 67 Bayer HealthCare Onyx Pharmaceuticals 67 DAVANAT 67 tumor necrosis 67 HepDirect prodrug 67 cathepsins 67 GERD migraine headaches 67 Gastrointestinal Stromal Tumors 67 Autoantibodies 67 Zemiva ™ 67 missense mutations 67 relapsed MM 67 cardio renal 67 Alocrest 67 vaccine GRNVAC1 67 inducible nitric oxide synthase 67 TRAIL R1 67 BEXXAR Therapeutic Regimen 67 Kahalalide F 67 potently inhibit 67 TRPV1 agonist 67 small molecule defensin 67 plasma kallikrein 67 Recombinant interferon alpha 67 Non Alcoholic Steatohepatitis 67 Lymphoid 67 Malignant Glioma 67 gemcitabine Gemzar ® 67 Invasive fungal infections 67 Radiofrequency ablation 67 Candida infection 67 R roscovitine 67 EHT AGN 67 collagen sponge seeded 67 pharmacologically active isomer 67 ZOLINZA 67 isotypes 67 transthyretin mediated amyloidosis ATTR 67 neoplastic 67 receptors EGFR 67 IMiDs ® compound 67 PEGylated Fab fragment 67 GSTP1 67 endometrial hyperplasia 67 subependymal giant cell 67 evaluating picoplatin 67 Tß4 67 carcinoids originate 67 Ceflatonin 67 panitumumab Vectibix 67 chemically modified siRNA 67 Epothilones 67 targeting CD# 67 humanized anti 67 Nonalcoholic fatty liver 67 chemokine receptors 67 Cloretazine 67 IMiDs 67 chemotherapy induced neutropenia 67 hypoxia selective 67 Aurexis R 67 G Protein Coupled 67 cutaneous T cell 67 Cariprazine 67 Symadex 67 Aromatase 67 biomarker identification 67 p# inhibitor 67 idarubicin 67 IDH mutations 67 RhuDex R 67 Omacetaxine 67 acute humoral rejection 67 c KIT 67 systemic amyloidosis 67 TRIOLEX HE# APOPTONE HE# 67 Metastases 67 vascular disrupting agents 67 CCR1 67 apoptosis proteins 67 simplex virus 67 Ocrelizumab 67 LRP6 67 5 HT4 67 GI motility disorders 67 Hypoxia Inducible Factor 67 PORxin TM platforms 67 MEK ERK 67 antibody MAb 67 nucleoside analogs 67 systemic lupus erythematosus SLE 67 targeted anticancer biopharmaceuticals 67 Metastatic Melanoma 67 EGFR inhibitors 67 Cytotoxic T 66 extracellular signal 66 novel topoisomerase 66 severe hepatomegaly 66 coagulation cascade 66 Daclizumab 66 effector function 66 TNF alpha selectively neutralizing 66 Maroteaux Lamy syndrome 66 Basal cell 66 neuronal nicotinic receptor NNR 66 factor HGF 66 Chronic Myeloid Leukemia 66 Squamous cell 66 systemic lupus erythematosus 66 CCR9 antagonist 66 Prodarsan ® 66 non nucleoside inhibitor 66 dermatological disorders 66 HER2 HER3 66 potent antiproliferative 66 RAF kinase 66 protein kinase inhibitor 66 telomerase inhibitor 66 neoplastic diseases 66 interferon gamma 1b 66 renal dysfunction acute renal 66 inhibit oxidative stress 66 HER2 receptor 66 Apaziquone 66 MT#/MEDI-# 66 Diabetic Nephropathy 66 NMDA antagonist 66 DDP# 66 recombinant PSMA vaccine 66 fosbretabulin 66 IGF IR 66 R sorafenib tablets 66 hyperphosphorylation 66 Leber Hereditary Optic Neuropathy 66 MEK1 66 liver cancers hypercholesterolemia 66 AKT inhibitor 66 DURECT proprietary 66 Hos2 66 Oral Fingolimod 66 HGS ETR2 66 microcirculatory improvement helping 66 Acute Exacerbations 66 Cdc7 66 humanized monoclonal 66 antagomirs 66 castrate resistant prostate cancer 66 Ph + acute lymphoblastic 66 Primary Hypercholesterolemia 66 metabolic disorders Saizen R 66 Pathway Inhibitor 66 rheumatoid arthritis psoriatic arthritis 66 cediranib 66 radiation chemoradiation 66 tumorigenicity 66 gastric carcinogenesis 66 autoimmune inflammatory 66 Annamycin 66 stage hypoxia activated 66 ON #.Na 66 sulfatase 66 receiving VELCADE 66 noninfectious uveitis 66 triggers apoptosis 66 alkylating agent 66 syngeneic 66 ZEVALIN therapeutic regimen 66 anti amnesic 66 Pafuramidine 66 peptide antigens 66 malignant ascites 66 oral leukoplakia 66 plasma kallikrein inhibitor 66 MEK Inhibitor 66 Anthracyclines 66 CDH1 66 vaso occlusive crisis 66 hepatorenal syndrome 66 immunomodulation 66 small molecule tyrosine 66 ACTIQ ® 66 immunotherapeutic agent 66 Regenerative Cells 66 Phase 2b Trial 66 IN PATIENTS WITH 66 Combivir Kivexa 66 JAK2 Inhibitor 66 Squamous Cell Carcinoma 66 class anticancer quinolone 66 nonbacterial prostatitis 66 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 66 paroxysmal nocturnal hemoglobinuria 66 Virulizin ® 66 proliferative disorders 66 Altera Nebulizer System 66 renal failure interstitial lung 66 SinuNase ™ 66 hyperphenylalaninemia HPA due 66 metastatic GIST 66 agonistic human 66 Pegloticase 66 hematopoietic cell 66 sapacitabine CYC# 66 SPRYCEL ® 66 Atypical Hemolytic Uremic Syndrome 66 serine proteases 66 oral transdermal 66 methylenetetrahydrofolate reductase 66 antimitotic 66 Irritable bowel syndrome 66 telomerase therapeutic 66 Polymorphisms 66 cytolytic 66 See CLINICAL PHARMACOLOGY 66 refractory anemia RA 66 acute leukemias 66 LEUKINE 66 TNF antagonist 66 CYP#C# [002] 66 CYC#